---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-24-000068"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2024-07-25T23:59:59+00:00"
generated_at: "2026-05-31T16:18:15.155017+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Salarius Pharmaceuticals files prospectus supplement for up to $335,921 ATM stock offering

## Summary
- Offering of up to $335,921 in common stock under existing ATM agreement with Ladenburg Thalmann & Co. Inc.
- Prospectus supplement filed on July 25, 2024, under effective registration statement (File No. 333-266589).
- Legal opinion of Hogan Lovells US LLP on share validity attached as Exhibit 5.1.

## SEC filing metadata
- accession: 0001615219-24-000068
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2024-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000068/0001615219-24-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000068/flks-20240725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-24-000068
- JSON: https://secwatch.observer/filing/0001615219-24-000068.json
- Plain text: https://secwatch.observer/filing/0001615219-24-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.